Tuesday, August 17, 2021 4:16:40 PM
New York Yankees and Duke Basketball
Recent VRPX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:05:48 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 05/16/2024 08:00:51 PM
- Virpax Announces Pricing of $2.25 Million Public Offering • Business Wire • 05/15/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/15/2024 04:15:26 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/13/2024 09:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:20:37 PM
- Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments • Business Wire • 05/13/2024 08:10:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:02:37 PM
- Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™ • Business Wire • 04/30/2024 11:30:00 AM
- Virpax Pharmaceuticals Reports 2023 Year-End Results • Business Wire • 03/26/2024 11:30:00 AM
- Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price • Business Wire • 02/27/2024 12:31:00 PM
- Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc. • Business Wire • 02/27/2024 12:30:00 PM
- Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research • Business Wire • 02/07/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:26:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:24:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:23:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:22:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:21:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 12:30:32 PM
- Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting • Business Wire • 12/29/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 01:30:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/07/2023 02:08:12 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM